GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » E10

Fisher & Paykel Healthcare (NZSE:FPH) E10 : NZ$0.47 (As of Sep. 2023)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Fisher & Paykel Healthcare's adjusted earnings per share data for the fiscal year that ended in Mar. 2023 was NZ$0.430. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NZ$0.47 for the trailing ten years ended in Mar. 2023.

During the past 3 years, the average E10 Growth Rate was 21.80% per year. During the past 5 years, the average E10 Growth Rate was 21.20% per year. During the past 10 years, the average E10 Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Fisher & Paykel Healthcare was 24.10% per year. The lowest was 2.50% per year. And the median was 12.15% per year.

As of today (2024-05-21), Fisher & Paykel Healthcare's current stock price is NZ$ 28.36. Fisher & Paykel Healthcare's E10 for the fiscal year that ended in Mar. 2023 was NZ$0.47. Fisher & Paykel Healthcare's Shiller PE Ratio of today is 60.34.

During the past 13 years, the highest Shiller PE Ratio of Fisher & Paykel Healthcare was 144.92. The lowest was 24.00. And the median was 63.07.


Fisher & Paykel Healthcare E10 Historical Data

The historical data trend for Fisher & Paykel Healthcare's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare E10 Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.26 0.34 0.42 0.47

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.42 - 0.47 -

Competitive Comparison of Fisher & Paykel Healthcare's E10

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fisher & Paykel Healthcare's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's Shiller PE Ratio falls into.



Fisher & Paykel Healthcare E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fisher & Paykel Healthcare's adjusted earnings per share data for the fiscal year that ended in Mar. 2023 was:

Adj_EPS=Earnings per Share (Diluted) /CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=0.43/124.5168*124.5168
=0.430

Current CPI (Mar. 2023) = 124.5168.

Fisher & Paykel Healthcare Annual Data

per_share_eps CPI Adj_EPS
201403 0.174 99.396 0.218
201503 0.199 99.646 0.249
201603 0.251 100.063 0.312
201703 0.295 102.231 0.359
201803 0.330 103.355 0.398
201903 0.362 104.889 0.430
202003 0.496 107.547 0.574
202103 0.904 109.182 1.031
202203 0.650 116.747 0.693
202303 0.430 124.517 0.430

Add all the adjusted EPS together and divide 10 will get our e10.


Fisher & Paykel Healthcare  (NZSE:FPH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Fisher & Paykel Healthcare's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=28.36/0.47
=60.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Fisher & Paykel Healthcare was 144.92. The lowest was 24.00. And the median was 63.07.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Fisher & Paykel Healthcare E10 Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.